9th SA AIDS Conference 2019

SA AIDS Conference 2019

Unprecedented innovations and technologies: HIV and change

The 9th South African AIDS Conference took place from 11-14 June 2019 in Durban, South Africa, and focused on unprecedented scientific, social and digital innovations/technologies which could expand possibilities and opportunities towards controlling the HIV and AIDS epidemic. The conference aimed to determine how contemporary explosive and disruptive technologies can contribute towards sustained HIV prevention efforts, HIV testing, ART uptake and adherence, trigger the development of new drugs, effectively utilise enormous volumes of data, and improve communication and service delivery, and eventually end the epidemic.  

Milestones, initiatives, strategies, models, systems and best practices in accelerating the control of the epidemic ahead of the 2020 global targets were highlighted through the following five conference tracks:

  • Track 1: Clinical science and bio-medical innovations, technologies and responses 
  • Track 2: Possibilities and limits of big data - Epidemiology, mathematical modelling & surveillance
  • Track 3: Implementation science: Technologies, innovations and methods for scaling up effective interventions
  • Track 4: Social drivers of the epidemic: Society, race, class, culture, stigma, violence, diversity and challenges
  • Track 5: Social justice: Relationships and power – community, policies, laws, health systems, human rights, donor agencies and the state

Browse this page for updates, related content, and live coverage from the conference!

Visit www.saaids.co.za to download the conference programme [29MB] and oral and poster abstract book [1.2MB].

May 28, 2019
Year of publication
2019
Resource types
Conference
Countries
Tags
9th South African AIDS Conference, HIV prevention, HIV testing and counseling (HTC), antiretroviral therapy (ART), HIV self-testing (HIVST), SA AIDS 2019
Johanna Theunissen

SHARE presentation at SA AIDS 2019

Johanna Theunissen, Communications Officer at Technical Support to PEPFAR Programs (TSP), Baylor College of Medicine Children’s Foundation Malawi, presented at the 2019 South African AIDS Conference (SA AIDS 2019) on the innovative use of technology through SHARE's online platform and social media. Take a look at the presentation here.
GRS team

Scoring big with Grassroot Soccer at SA AIDS 2019

The biennial South African AIDS Conference (SA AIDS 2019), which took place earlier this month in Durban, South Africa, was an opportunity to meet a diverse range of players in the field of HIV and AIDS -- and one of the most innovative and inspiring of these is definitely Grassroot Soccer (GRS), so the SHARE team was really excited to get the chance to chat with some of the organization’s coaches, or young adult mentors, and master trainers about the work they are doing and what brought them to the conference.
ECHO press release

Pivotal ECHO Study Provides Reassuring Evidence on HIV Risk and Contraceptives

Results of a pivotal clinical trial among 7,829 women ages 16-35 in East and Southern Africa provide important evidence to help inform women’s choices for contraception and HIV prevention. The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study found no substantial difference in HIV risk among women using the three methods of contraception in the study – the copper-releasing intrauterine device (Cu-IUD), a levonorgestrel (LNG) implant (Jadelle) and depot medroxyprogesterone acetate-intramuscular (DMPA-IM), also known as Depo-Provera.
ECHO study results_Lancet

HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial

Injectable, intrauterine, and implantable contraceptives have been prioritised for programmatic delivery because of high contraceptive efficacy and safety. Robust evidence on the relative risks, particularly HIV susceptibility, and benefits of these contraceptive methods is important to inform women's decision making, provider counselling, and policy maker and regulatory decisions. Our primary objective was to compare HIV incidence among women using DMPA-IM, a copper IUD, or a levonorgestrel (LNG) implant.
eThekwini Declaration

Our key takeaways from SA AIDS 2019

Reflecting on this year’s South African AIDS Conference, the SHARE team identified six key messages.
Global Fund baseline assessment

Scaling up Programs to Reduce Human Rights-Related Barriers to HIV and TB services: Baseline assessment –South Africa

This report documents the results of a baseline assessment carried out in South Africa to support its efforts to scale up programs to reduce human-rights-related barriers to HIV and TB services.
MSF School Health Program Implementation Toolkit

MSF School Health Program Implementation Toolkit

As South Africa seeks to implement national policies on school-based health education and services it is important that the evidence and experiences of existing school health programs be accessible to service providers and role-players. It is for this reason that Médecins Sans Frontières/Doctors Without Borders (MSF) has developed this School Health Program “toolkit”, detailing the approach followed in partnership with the KwaZulu-Natal Department of Health in developing the MSF School Health Program in King Cetshwayo District in KwaZulu-Natal Province.
Leora Casey

Battling the perfect storm

At the 9th South African AIDS Conference (SA AIDS 2019), I can only reflect on the work we have done over the years in the fight against HIV. So many inspiring scientists, community representatives and activists in the room working to turn the tide on this virus. ‘Unprecedented innovation and technologies’ was a fitting theme for this year’s biennial conference: 19 years on from the first SA AIDS Conference, South Africa has become a world leader in the work to end AIDS.
ECHO presentation

A Roadmap for Results - Understanding the ECHO Trial Findings

Results from the Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study were released at a session at the 9th South African AIDS Conference (SA AIDS 2019) in Durban, South Africa, on Thursday, June 13th. The session, which included presentations on the primary analysis, was recorded and can be viewed on YouTube here.
ECHO study Fact Sheet

ECHO Study Factsheet

The Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study is an open-label randomised clinical trial comparing three highly effective, reversible methods of contraception — a progestogen-only injectable called depot-medroxyprogesterone acetate (DMPA), a levonorgestrel implant and the non-hormonal copper intrauterine device — to evaluate whether there is any difference in the risk of acquiring HIV infection among users of these methods.Read this fact sheet for more about the ECHO study.
SA AIDS 2019 blog

SHARE-ing social media strategies for success: What’s worked for us

The Southern Africa HIV and AIDS Regional Exchange (SHARE) was first developed in 2011 to address the need for a free, user-friendly space for online knowledge sharing of locally-relevant HIV and AIDS information. Since its inception, SHARE has connected thousands of people to resources, peers, organizations, online learning, and tools for collaboration. Almost daily, SHARE posts new content to its social media profiles on Facebook and Twitter to further amplify what the platform has to offer. SHARE’s experiences have led to a new wealth of knowledge on what it takes to lead a successful social media strategy. Presented here are a few tips based on what has worked for us.
Anele Yawa, TAC

Participants’ expectations for the South African AIDS Conference

The SHARE team chatted with a range of delegates to find out their expectations for this week’s conference, including academics, clinicians, and representatives from civil society organizations.

Similar Resources

In our third issue, we have assembled 72 abstracts published from April through May 2018 that feature articles from Botswana (4), Lesotho (2), Malawi (7), Mozambique (5), South Africa (43), Swaziland (2), Tanzania (4), Zambia (2) and Zimbabwe (9).
In our fourth issue, we have assembled 68 abstracts published from June through July 2018 that feature evidence from Angola (1), Botswana (1), Eswatini (2), Malawi (11), Mozambique (3), South Africa (36), Zambia (6) and Zimbabwe (10).
In our fifth issue, we have assembled 70 abstracts published from August through September 2018 that feature evidence from Botswana (3), Eswatini (5), Lesotho (2), Malawi (8), Mozambique (3), Namibia (3), South Africa (40), Tanzania (1), Zambia (12) and Zimbabwe (9).
In our sixth issue, we have assembled 105 abstracts published from October through December 2018 that feature evidence from Botswana (4), Eswatini (5), Lesotho (2), Malawi (8), Mozambique (6), Namibia (2), South Africa (62), Tanzania (1), Zambia (12) and Zimbabwe (10).
In this, our 7th, issue, we have assembled 67 abstracts published from January through February 2019 that feature evidence from Botswana (3), Eswatini (2), Lesotho (2), Malawi (16), Mozambique (3), South Africa (40), Tanzania (2), Zambia (3) and Zimbabwe (7).
In our 8th issue of our Research Digest, we have assembled 64 abstracts published from March through April 2019 that feature evidence from Botswana (2), Eswatini (2), Lesotho (2), Malawi (12), Mozambique (4), Namibia (1), South Africa (32), Tanzania (3), Zambia (11) and Zimbabwe (14).
Our 9th Research Digest assembles 87 abstracts published from May through June 2019 that feature evidence from Botswana (6), Eswatini/Swaziland (2), Malawi (12), Mozambique (4), South Africa (46), Tanzania (4), Zambia (7) and Zimbabwe (17).
In this issue of the research Digest, we have assembled 86 abstracts published in July and August 2019 that feature evidence from Botswana (4), Burundi (1), Democratic Republic of Congo (1), Eswatini (3), Lesotho (4), Malawi (3), Mozambique (7), South Africa (51), Zambia (10) and Zimbabwe (9).…

The International AIDS Conference (IAC) is by far the largest conference on HIV related issues. This prestigious conference is the premier gathering for those working in the field of HIV, as well as policy makers, people living with HIV and others committed to ending the epidemic.

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.